Prokineticin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Authors

  • Rebecca Hills University of Edinburgh
  • Philippe Rondard Université de Montpellier https://orcid.org/0000-0003-1134-2738
  • Oualid Sbai Université de Montpellier
  • Qun-Yong Zhou University of California Irvine

DOI:

https://doi.org/10.2218/gtopdb/F56/2019.4

Abstract

Prokineticin receptors, PKR1 and PKR2 (provisional nomenclature as recommended by NC-IUPHAR [23]) respond to the cysteine-rich 81-86 amino-acid peptides prokineticin-1 (also known as endocrine gland-derived vascular endothelial growth factor, mambakine) and prokineticin-2 (protein Bv8 homologue). An orthologue of PROK1 from black mamba (Dendroaspis polylepis) venom, mamba intestinal toxin 1 (MIT1, [65]) is a potent, non-selective agonist at prokineticin receptors [41], while Bv8, an orthologue of PROK2 from amphibians (Bombina sp., [44]), is equipotent at recombinant PKR1 and PKR2 [48], and has high potency in macrophage chemotaxis assays, which are lost in PKR1-null mice.

Published

16-Sep-2019

How to Cite

Hills, R. (2019) “Prokineticin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database”, IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). doi: 10.2218/gtopdb/F56/2019.4.

Issue

Section

Summaries